$DAL

CNBC’s ‘Final Trades’: Delta Air, Target, Thermo Fisher Scientific - Delta Air Lines (NYSE:DAL)

CNBC's 'Final Trades' featured picks from analysts, including Delta Air Lines (DAL) for its strong Q2 earnings, Thermo Fisher Scientific (TMO) for its raised FY2026 guidance, and Target (TGT) for its better-than-expected Q2 results. Interactive Brokers (IBKR) was also mentioned for its new Latin America funding solution. DAL +1.4%, TMO -0.1%, TGT -3.8%, IBKR +5.5%.

Original reporting
Published Aug 26, 2026, 11:11 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 26, 2026, 1:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$DAL
Bullish
high confidence
Mentioned
$DAL · $TMO · $TGT · $IBKR
Relevance
7/10
AlphAI data visualization · based on benzinga.com
Decision brief

The 30-second read

$DALBullishMed
01

Why it matters

Each company’s latest earnings or product announcement provides a fresh data point for short‑term traders.

02

Market read

Earnings beats and a new product launch create short‑term trading opportunities across multiple sectors.

03

What to watch

Potential headwinds for airlines from fuel costs and for retailers from inflationary pressure could temper upside.

Relevance 7/10Novelty 7/10Timing: same-day

Background

The article summarizes final trade picks from a CNBC segment, highlighting recent earnings beats and a new product launch.

Company-level read

Ticker impact

$DALBullishHigh confidence
Context

Delta Air posted Q2 earnings of $1.56 EPS beating $1.47 consensus, driving a 1.4% price rise.

Expected impact

modest upside over next few days

Evidence & confidence

Beat was modest but above expectations; market already priced in part of the surprise.

$TMONeutralMedium confidence
Context

Thermo Fisher reported Q2 results that beat estimates and raised FY2026 guidance, with shares slipping 0.1% intraday.

Expected impact

stable to slightly higher as guidance is incorporated

Evidence & confidence

Guidance lift is positive, but market reaction was muted.

$TGTBearishMedium confidence
Context

Target posted Q2 results above expectations and lifted FY26 EPS and sales guidance, shares fell 3.8% on the day.

Expected impact

potential further downside if guidance is deemed insufficient

Evidence & confidence

Despite beat, market may be pricing in broader retail concerns.

$IBKRBullishMedium confidence
Context

Interactive Brokers announced a new funding solution for Latin America clients via Paysafe’s SafetyPay on Aug 18.

Expected impact

moderate upside if rollout succeeds

Evidence & confidence

Product launch is a fresh catalyst; stock already up 5.5% on the day.

Market effects

Airline earnings beat supports broader travel sector optimism; retail earnings highlight pressure on consumer spending.

U.S. equities see mixed reactions across transportation, healthcare, and consumer discretionary.

Limited; primarily U.S. market focus.

Counterpoint

Despite earnings beats, the modest price moves suggest the market may have already priced in the news; caution on overtrading.

Key entities

  • Delta Air Lines

    Airline reporting Q2 earnings beat.

  • Thermo Fisher Scientific

    Life‑sciences firm raising FY2026 guidance.

  • Target Corporation

    Retailer with Q2 beat and guidance lift.

  • Interactive Brokers Group

    Broker launching LATAM funding solution.

Related articles

$BULLHighAI 8/10

Webull Sinks 29% as House Panel Calls Its China Ties a National Security Risk; Robinhood Drops 3%, Interactive Brokers Slips

Webull (BULL) stock dropped 29% to $5.15 after a House panel cited its China ties as a national security risk. Robinhood (HOOD) fell 3% to $108.93, and Interactive Brokers (IBKR) slipped 2% to $88.77. The panel's report highlighted Webull's ownership, workforce, and data routing as concerns, while the broader market saw minimal impact.

$AXPMed

JPMorgan reveals stocks worth buying in October 2026

JPMorgan added five stocks to its Overweight list, highlighting American Express (AXP) as a Value pick, Thermo Fisher (TMO) and Liberty Energy (LBRT) as Growth picks. AXP is down 18-19% YTD but JPMorgan sees steady profits and share buybacks. TMO is up 25% in 3 months, with growth driven by partnerships and AI-powered lab machines. LBRT is up 52% in 12 months, benefiting from AI data center power demands.

$QNTMMed

Quantum BioPharma Taps Thermo Fisher for Lucid-MS Phase 2 Trial in Multiple Sclerosis

Quantum BioPharma (QNTM) has partnered with Thermo Fisher Scientific to begin Phase 2 trials for Lucid-MS, a treatment for progressive multiple sclerosis. The FDA has cleared the trial, which will assess efficacy, safety, and tolerability. Thermo Fisher will provide clinical research services. Success could offer a new treatment option for MS, a condition with limited therapies. Quantum owns 19.84% of Unbuzzd Wellness and receives royalties from it.

$QNTMMedAI 8/10

Quantum BioPharma Advances Multiple Sclerosis Trial with Thermo Fisher Partnership

Quantum BioPharma (QNTM) partnered with Thermo Fisher Scientific to start a Phase 2 trial for Lucid-MS, a treatment for progressive multiple sclerosis. The trial, cleared by the FDA, will assess efficacy, safety, and tolerability. Lucid-MS targets myelin degradation, differing from existing therapies. Quantum owns 19.84% of Unbuzzd Wellness, with royalty agreements in place.